On-demand webinar

ZEISS Educational Webinar

Spotlight on ZEISS IOLs: Evidence-based Insights from ESCRS 2025 Summary
11 December 2025 · 33 min watch
Image of Professor Gerd Auffarth, FEBO
Moderator Professor Gerd Auffarth, FEBO Professor and Chairman of the Department of Ophthalmology at the Ruprecht-Karls-University Heidelberg, Germany

Director of the David J. Apple International Laboratory for Ocular Pathology, and Director of the International Vision Correction Research Centre (IVCRC).

SUMMARY

Spotlight on ZEISS IOLs:
Evidence-based Insights from ESCRS 2025 – Summary

The third webinar episode provides insights into IOL and patient selection strategies, focusing on recent findings from the ESCRS 2025 in Copenhagen. The discussion highlights the importance of selecting the appropriate IOL for individual patient needs.

Prof. Auffarth highlights the shift from excluding patients to selecting the right IOL for specific needs, with a focus on various lens types and optical designs.

Key insights include:

  • Patient Selection: Factors like refractive status, daily activities, and personality influence IOL choice. The approach has evolved from exclusion to personalized selection.

  • IOL Options: IOLs are designed to address specific needs, such as monofocal technology for basic vision correction and trifocal technology for high degree of spectacle independence.

  • IOL Platforms: ZEISS offers two platforms: hydrophilic 4-point haptic and hydrophobic c-loop designs in pre-loaded injector systems

  • Visual Outcomes: Studies reveal excellent contrast sensitivity, very good distance and functional intermediate vision with monofocal lenses and continuous range of vision with trifocal lenses from ZEISS.

  • Patient Satisfaction: High satisfaction rates with low incidence of photic phenomena like halos and glare.
    The webinar concludes with recommendations for personalized approaches to IOL selection, emphasizing the importance of understanding patient needs and preferences.

Share this article